This article is more than 5 years old. Information may no longer be current.

Visco 360 system approved by Health Canada

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Health Canada has approved the Visco 360 viscosurgical system for the microcatheterization and transluminal viscodilation of Schlemm’s canal to reduce IOP in adults with open-angle glaucoma, according to a Sight Sciences press release.

The single-handed, single-use device combines a custom-access cannula, a soft and flexible microcatheter with an atraumatic tip, an internal infusion pump, gear mechanism and viscoelastic reservoir, the release said.

“Catheterizing and viscodilating Schlemm’s canal by way of the more efficient ab interno approach is a safe and exciting new MIGS procedure,” Ike K. Ahmed, MD, FRCSC, who completed the first commercial Visco 360 cases in Canada, said in the release. “The Visco 360 system simplifies canaloplasty and allows for complete access to Schlemm’s canal using a single clear corneal incision and a single-handed device.”